glp 1 pen GLP-1 Agents' Risks and Benefits Broader Than Previously Thought GLP-1s appear to cut cancer
Description
Like LIR, the race of patients involved in related clinical studies is relatively small
Given that GLP-1RAs are demonstrating efficacy in diseases beyond weight loss and diabetes, their use is only going to increase
Compounded Semaglutide as an Ozempic Alternative Compounded semaglutide injections contain identical semaglutide molecules to Ozempic but cost a fraction of the brand price
Meta-analyses have confirmed the benefit of GLP-1 RAs as a class in both secondary and primary prevention of cardiovascular disease, and in reduction of adverse kidney outcomes in people with T2D (Kristiensen et al, 2019
Zeng Y, Wu Y, Zhang Q, et al
While GLP-1 agents alone rarely cause hypoglycemia due to their glucose-dependent mechanism, combination therapy increases this risk
